Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post Market Clinical Follow-Up of OrthoPureXT for the Treatment of Multiligament Injured Knee: a Case Series

NCT05655156 is registered in ClinicalTrials.gov with Tissue Regenix Ltd as lead sponsor.

NCT NCT05655156
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05655156 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post Market Clinical Follow-Up of OrthoPureXT for the Treatment of Multiligament Injured Knee: a Case Series
Lead sponsor
Tissue Regenix Ltd
Phase
Not applicable
Overall status
Recruiting
Start date
April 30, 2025
Completion date
December 31, 2026
Enrollment
28 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiligament knee injuries